| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-11 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-10 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |